Wenting Shang

Le-Ping Zhang 1 collaboration

Ai-Dong Lu 1 collaboration

Jun Wu 1 collaboration

Yue-Ping Jia 1 collaboration

Ying-Xi Zuo 1 collaboration

Yong-Hua Zhang 1 collaboration

Yong-Hong Zhao 1 collaboration

Wei Shang 1 collaboration

Dong-Feng Xie 1 collaboration

Ying-Chun Li 1 collaboration

Zhao Sun 1 collaboration

Shui-Qing Ma 1 collaboration

Rui Xiong 1 collaboration

Leike Zhang 1 collaboration

Shiliang Li 1 collaboration

Yuan Sun 1 collaboration

Minyi Ding 1 collaboration

Yong Wang 1 collaboration

Yongliang Zhao 1 collaboration

Yan Wu 1 collaboration

Weijuan Shang 1 collaboration

Xiaming Jiang 1 collaboration

Jiwei Shan 1 collaboration

Zihao Shen 1 collaboration

Yi Tong 1 collaboration

Liuxin Xu 1 collaboration

Yu Chen 1 collaboration

Yingle Liu 1 collaboration

Gang Zou 1 collaboration

Dimitri Lavillete 1 collaboration

Zhenjiang Zhao 1 collaboration

Rui Wang 1 collaboration

Lili Zhu 1 collaboration

Gengfu Xiao 1 collaboration

Ke Lan 1 collaboration

Honglin Li 1 collaboration

Ke Xu 1 collaboration

Wenwen Shang 1 collaboration

Lei Wu 1 collaboration

Rui Xu 1 collaboration

Xian Chen 1 collaboration

Shasha Yao 1 collaboration

Peijun Huang 1 collaboration

Fang Wang 1 collaboration

Shu-Fen Huo 1 collaboration

Wen-Li Shang 1 collaboration

Min Yu 1 collaboration

Xiao-Ping Ren 1 collaboration

Hong-Xia Wen 1 collaboration

Chun-Yan Chai 1 collaboration

Li Sun 1 collaboration

Ke Hui 1 collaboration

Ling-Hua Liu 1 collaboration

Sheng-Hong Wei 1 collaboration

Xiao-Xiao Wang 1 collaboration

Yi Wang 1 collaboration

Ying-Xuan Tian 1 collaboration

Publications (4)

Expanded activated autologous lymphocyte infusions improve outcomes of low- and intermediate-risk childhood acute myeloid leukemia with low level of minimal residual disease.

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.

Clinical laboratory features of Meigs' syndrome: a retrospective study from 2009 to 2018.

STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.

Réseau de co-auteurs